Details
Ibandronic Acid
Prevention of skeletal lesions (pathological fractures, bone marrow defects requiring radiation therapy or surgical treatment) in patients with breast cancer and metastatic bone marrow defects.
Treatment of hypercalcemia in malignant neoplasms with or without metastases.
Contradictions
Hypersensitivity to ibandronic acid or to any other component of the drug.
Hypocalcemia.
Dosage & Administration
Treatment with ibandronic acid should only be prescribed by a physician experienced in the treatment of malignant neoplasms.
Prophylaxis of bone damage in patients with cancer and metastatic lesions of bone tissue: 6 mg intravenously for at least 15 minutes 1 time in 3-4 weeks after preliminary dilution in 100 ml of 0.9% solution of sodium chloride or 100 ml of 5% solution of glucose.
You have no items to compare.